Document Type

Technical Report

Publication Date



Public-private sector cooperation, Fellowships, Intellectual cooperation, United States. Food and Drug Administration, Science and state


Maintaining active interactions with the broad external scientific community is vital for FDA to fulfill its expanding public health mission. It is essential for the Agency to be well positioned to address emerging areas of regulatory science and rapidly advancing technologies.

Scientific engagement also helps FDA accomplish its mission by increasing awareness of FDA’s responsibilities and helping with the Agency’s critical recruitment and succession planning needs. FDA uses a range of mechanisms for scientific exchange. The Subcommittee was charged with considering:

a. how FDA can improve its interface with the outside scientific community, particularly regarding public-private partnerships (PPPs) and fellowship programs and

b. how the Reagan-Udall Foundation for FDA (RUF) can support both of these areas.


Note: At the time of writing, Mark McLellan was affiliated with Utah State University.

Persistent Identifier